Cotrimoxazole is a WHO-approved antibiotic combination of sulphamethoxazole and trimethoprim, which possesses synergistic effects against bacteria due to its cidal action while reducing resistance development. It is effectively used for various infections including urinary tract, respiratory tract, and gastrointestinal infections, and is well-tolerated with some adverse effects like gastrointestinal disturbances and blood disorders. However, it is contraindicated during pregnancy.